Uncovering middle managers' role in healthcare innovation implementation by Birken, Sarah A et al.
DEBATE Open Access
Uncovering middle managers’ role in healthcare
innovation implementation
Sarah A Birken
1*, Shoou-Yih Daniel Lee
2 and Bryan J Weiner
3
Abstract
Background: Middle managers have received little attention in extant health services research, yet they may have a
key role in healthcare innovation implementation. The gap between evidence of effective care and practice may be
attributed in part to poor healthcare innovation implementation. Investigating middle managers’ role in healthcare
innovation implementation may reveal an opportunity for improvement. In this paper, we present a theory of middle
managers’ role in healthcare innovation implementation to fill the gap in the literature and to stimulate research that
empirically examines middle managers’ influence on innovation implementation in healthcare organizations.
Discussion: Extant healthcare innovation implementation research has primarily focused on the roles of physicians
and top managers. Largely overlooked is the role of middle managers. We suggest that middle managers influence
healthcare innovation implementation by diffusing information, synthesizing information, mediating between
strategy and day-to-day activities, and selling innovation implementation.
Summary: Teamwork designs have become popular in healthcare organizations. Because middle managers
oversee these team initiatives, their potential to influence innovation implementation has grown. Future research
should investigate middle managers’ role in healthcare innovation implementation. Findings may aid top managers
in leveraging middle managers’ influence to improve the effectiveness of healthcare innovation implementation.
Keywords: Middle managers, Healthcare, Innovation implementation
Background
Middle managers’ responsibility in healthcare organiza-
tions has grown as teamwork designs have become popu-
lar in the industry. Teams of clinicians and administrators
are often tasked with implementing healthcare innovations
[1]. Middle managers–employees who are supervised by
an organization’s top managers and who supervise front-
line employees [2]–oversee the implementation of these
i n n o v a t i o n s[ 3 ] .A sm i d d l em a n a g e r s ’ responsibility in
healthcare organizations increases, their potential influ-
ence over innovation implementation grows.
Despite their potential influence, middle managers have
received little attention in extant healthcare innovation
implementation research. A comprehensive understanding
of middle managers’ role in innovation implementation is
important because of the gap between evidence of effective
care and practice. One study found that patients received
just one-half of recommended preventive care, acute care,
and care for chronic conditions; some patients received
care that was not recommended and was potentially harm-
ful [4]. Further, disparities in access to care and health
outcomes exist among racial and ethnic minorities, low-
income individuals, and women: In comparison with
whites, racial and ethnic minorities suffer from higher
rates of diseases such as cancer, obesity, and AIDS [5].
Despite recent concerns about disparities in cardiovascular
care, men continue to receive better treatment for heart
disease than women [6]. Research has also found signifi-
cant variation in measures of healthcare quality such as
safety climate and patient experience across practice sites
and units [7,8]. Many of these disparities can be attributed
to failure of healthcare organizations to provide evidence-
based care.
The gap between evidence and practice can be closed
only if healthcare organizations begin to adopt evidence-
based practices. However, implementing even seemingly
simple healthcare innovations has proven to be challenging.
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initiatives, for example, are less than 50% [9]. Poor imple-
mentation rates may be due to the substantial organiza-
tional changes required for the initiatives [9]. Indeed,
implementing innovations is demanding of employees and
organizations–cognitively, emotionally, physically, and
spiritually. When attempting to implement innovations,
organizations face challenges such as misaligned incentives,
professional barriers, competing priorities, and inertia [10].
In this paper, we present a theory of middle managers’
role in healthcare innovation implementation. The theory
is premised on the notion that middle managers have the
potential to bridge informational gaps that might other-
wise impede innovation implementation. Variation in
healthcare quality may be related to poor communication
of key strategic and clinical information across practice
sites and units [7,8]. By bridging informational gaps, mid-
dle managers may help to manage the demands associated
with innovation implementation, align incentives, trans-
cend professional barriers, and identify priorities to pro-
mote innovation implementation.
We use the Health Disparities Collaborative (HDC) to
provide practical examples of the constructs in our theory.
The Health Resources and Services Administration’s
Bureau of Primary Health Care, which funds health cen-
ters in underserved communities in the United States,
developed the HDC with the goals of eliminating health
disparities by narrowing the gap between evidence and
practice in federally qualified health centers [11]. The
objectives of the HDC were to decrease or delay disease
complications, reduce the economic burden, and improve
access to quality chronic disease care for underserved
populations, and to develop infrastructure, leadership, and
expertise in health centers. Participating health centers
were expected to use the following strategies: forming QI
teams; creating a registry of patients with chronic diseases
to help track clinical care; attending one national and
three regional learning sessions where teams learned
about the Chronic Care Model [12] and Plan-Do-Study-
Act cycles using the Breakthrough Series process [13]; and
engaging in activities to promote the implementation of
the HDC including the HDC listserv, web page, virtual
classroom, conference calls, and feedback on monthly
HDC progress reports from regional coordinators and
employees.
We begin the paper by discussing the gap in extant lit-
erature on healthcare innovation implementation, which
has paid little attention to middle managers’ role, focus-
ing instead on the roles of top managers and physicians.
This is followed by a brief review of literature that has
suggested that middle managers influence innovation
implementation in industries other than healthcare. We
then describe four ways in which middle managers may
contribute to implementation climate, which in turn
influences healthcare innovation implementation effec-
tiveness. This is followed by a brief discussion of factors
that may influence middle managers’ role in healthcare
innovation implementation. We conclude by suggesting
areas for research on middle managers’ role in healthcare
innovation implementation and discussing the implica-
tions of our theory for practice.
Scope
In this paper, we present a theory of how middle man-
ager may influence the effectiveness of healthcare innova-
tion implementation. As such, our theory exclusively
focuses on the relationship between middle managers’
commitment to healthcare innovation implementation
and implementation effectiveness. Our theory lies at the
organizational level. Although middle managers in
healthcare organizations exercise their influence on other
organizational members on an individual basis, our the-
ory focuses on the contributions that middle managers
make to promote consistent, high-quality innovation use
at the organizational level.
Discussion
Middle managers are largely overlooked in extant
healthcare innovation implementation effectiveness
research
An innovation is ‘an idea, practice, or object that is per-
ceived as new by an individual or another unit of adoption’
[14]. For example, the HDC was an innovation because,
although some employees may have engaged in QI initia-
tives before the HDC, the HDC was a distinct, major
initiative that employed strategies that were unfamiliar to
health center employees [15]. Implementation is ‘the tran-
sition period during which targeted organizational mem-
bers ideally become increasingly skillful, consistent, and
committed in their use of an innovation’ [16]. For exam-
ple, the HDC guided health centers in improving chronic
disease care by developing infrastructure, leadership, and
expertise through continuous learning, change, and
improvement. At first, some employees perceived continu-
ous learning, change, and improvement processes as an
inefficient use of time, but ultimately, many employees
came to rely on these methods to improve infrastructure,
leadership, and expertise. Innovation implementation,
then, refers to a process in which organizational members
become proficient in their use of a new practice. We posit
that innovation implementation is a process that middle
managers may facilitate by engaging in activities specifi-
cally related to innovation implementation, thereby
improving implementation effectiveness. Implementation
effectiveness refers to the aggregate, organization-level
consistency and quality of targeted organizational mem-
bers’ use of an innovation [16]. It is a multidimensional
construct that includes reach (appropriateness), dose of
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received (consistency), and level of integration (fidelity)
[17]. Our theory focuses specifically on the degree to
which an innovation’s components are integrated into its
practices (fidelity) because it is indicative of an organiza-
tion’s potential to achieve an innovation’si n t e n d e do u t -
comes [14,18], and we are interested in assessing middle
managers’ contribution to healthcare organizations’
achievement of innovations’ intended outcomes. The pre-
sence of community linkages, for example, is one indica-
tion that the HDC was effectively implemented; linking
patients with community-based resources such as senior
centers and exercise programs allowed patients to benefit
from resources that are not available within many health-
care organizations.
Despite a growing literature on healthcare innovation
implementation, middle managers’ role has received little
attention. Health services researchers have only recently
begun to acknowledge the importance of innovation
implementation. Previously, it was often assumed that
implementation was unproblematic and would proceed as
planned once a decision was made to adopt an innovation.
Alexander, however, found that, relative to studies of
healthcare innovation adoption, little research has assessed
innovation implementation [9]. As a result, estimates of
healthcare innovation effectiveness may be misleading.
Health services researchers increasingly recognize that,
until an innovation is effectively implemented, the results
of the innovation itself cannot be assessed.
Despite recent acknowledgement of its importance, the
literature on healthcare innovation implementation remains
in its infancy. To date, health services researchers have pri-
marily focused on investigating the roles of top managers
and physicians in innovation implementation. Early
research focused on the role of physicians [19,20], who
were identified as key facilitators in the implementation of
innovations such as communication skills training, evi-
dence-based practices, and depression QI initiatives
[21-23]. Helfrich et al. found that the implementation of
new programs in cancer prevention and control research
was related to physicians’ commitment [24]. Aarons et al.
found that organizational support for implementation
improved mental health service physicians’ attitudes toward
implementing evidence-based practices [25]. Flanagan et al.
found that training resources such as academic detailing,
grand rounds presentations, and clinical meetings increased
physicians’ acceptance of clinical practice guidelines; in
turn, physicians’ acceptance of clinical practice guidelines
increased implementation effectiveness [26]. In healthcare
organizations such as community mental health agencies,
researchers have identified physician resistance as a key
barrier to implementing QI initiatives [19,27].
Subsequent healthcare innovation implementation
research broadened its scope to investigate top managers’
role. Levinson et al. noted that implementation of commu-
nication skills training was greatly facilitated by top man-
agers’ commitment to the innovation [22]. Kimberly and
Cook suggested that the effectiveness of innovation imple-
mentation in mental health services was likely influenced
by top managers’ commitment [28]. Empirical research
has borne out this notion: Weiner et al. demonstrated that
the extent of clinical involvement in hospital QI efforts
was positively related to top managers’ commitment [29].
Physicians’ attitudes toward innovation implementation
and, subsequently, the implementation of a depression QI
initiative were also positively related to top managers’
commitment [21,30]. Likewise, the most commonly cited
implementation facilitator cited in Fremont et al.’ss t u d y
of HIV collaboratives in Veterans Health Administration
organizations was top managers’ commitment [31]. In
their study of the implementation of new programs in can-
cer prevention and control research, Helfrich et al. also
found that implementation policies that promoted a favor-
able implementation climate were facilitated by top man-
agers’ commitment; in turn, this favorable implementation
climate increased implementation effectiveness [24]. Proc-
tor et al. provided a particularly good example of the
marked focus of healthcare innovation implementation
research on top managers [27]. In a study of facilitators
and barriers to implementing evidence-based practices,
Proctor et al. interviewed mental health agency directors
[27]. The directors cited their own support as a primary
facilitator.
Middle managers are underrepresented in studies of
healthcare innovation implementation. Some authors
have emphasized that implementation effectiveness
depends on the ability and willingness of individuals to
implement them on the frontlines. Yet they leave unspe-
cified how top managers’ commitment is translated into
action on the frontlines and whose responsibility it is to
enable frontline employees to implement innovations
[10,19,32]. In their assessment of the roles of employees
and project teams in implementing new practices in hos-
pitals, Tucker et al. acknowledged that middle managers
supervise these employees and project teams [33]. Freed
suggested that lack of proper frontline management (i.e.,
middle managers) can stymie hospital turnarounds [34].
In their study of middle managers’ involvement in health-
care organizations’ strategy processes, Floyd and Wool-
dridge found that middle managers’ boundary-spanning
position allowed them to influence their superiors in top
management as well as frontline employees [35]. Middle
managers’ influence on frontline employees, they con-
cluded, was positively related to organizational outcomes
such as effectiveness, competitive position, efficiency, and
financial performance. Similarly, King and Zeithaml
found that middle managers in hospitals who were privy
to information regarding their organization’s competitive
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priate employees throughout the organization [36].
Although these papers suggest that middle managers
may influence healthcare innovation implementation,
none of the papers empirically assessed middle managers’
role in healthcare innovation implementation. In this
paper, we present a theory of middle managers’ role in
healthcare innovation implementation to promote such
research.
In contrast to research in healthcare, much research in
industries other than healthcare has suggested that middle
managers influence innovation implementation. This
research indicates that middle managers’ influence may be
positive or negative. On the one hand, middle managers’
commitment to innovation implementation has been
linked to strategy realization [37], efficiency of operations
[35], and implementation speed [38], as well as positive
organizational outcomes such as profit growth [39],
enhanced competitiveness [38], and overall effectiveness in
reaching established goals [35]. On the other hand, there
is evidence that middle managers may limit implementa-
tion effectiveness by speaking negatively of an innovation,
choosing to withhold information about an innovation,
stymying the flow of information about an innovation, or
preventing frontline employees from engaging in innova-
tion implementation activities. Floyd and Wooldridge, for
example, found that middle managers impeded innovation
implementation by ‘dragging their feet’ or pursuing other
priorities [37]. Sayer discussed how middle managers
revolted against the implementation of an innovation in a
public sector organization to maintain their position and
power, effectively bringing innovation implementation as
originally conceived by top managers to a halt [40]. Huy
similarly found that insufficient commitment among mid-
dle managers resulted in poor implementation in an infor-
mation technology firm [41]. Middle manager resistance
has also been cited as the primary obstacle to implement-
ing lean practices in manufacturing firms [42]. Ogbonna
and Wilkinson found that middle managers in a food retail
company who had concerns regarding an innovation
implemented the innovation only out of fear of sanction
from top managers. The authors warned that this culture
of fear may lead to unintended consequences such as
demoralization and diminishing performance in other
aspects of middle managers’ jobs [43]. Indeed, one middle
manager who oversaw HDC implementation, discouraged
by poor access to financial, human, and training resources,
described implementing the HDC as a futile task [44].
Research has helped to identify ways of encouraging
middle managers to positively influence innovation
implementation in industries other than healthcare. Simi-
lar research on middle managers’ role in innovation
implementation is lacking in healthcare. In this paper, we
present a theory of middle managers’ role in healthcare
innovation implementation with the goals of filling the
gap in the literature and stimulating research that empiri-
cally examines middle managers’ contribution to innova-
tion implementation in healthcare organizations. Such
research may help to identify ways of encouraging middle
managers to positively influence innovation implementa-
tion in healthcare.
Theory of middle managers’ role in healthcare innovation
implementation
Figure 1 displays our theory of middle managers’ role in
healthcare innovation implementation. In colloquial
terms, our theory suggests that middle managers give
employees information regarding innovation implemen-
tation; make it relevant to them; give them the tools
necessary to implement innovations; and encourage them
to consistently and effectively use those tools. Our theory
is premised on the notion that middle managers fill
structural holes in healthcare organizations [45]. Middle
managers’ strategic location between top managers and
frontline employees, such as physicians, mid-level provi-
ders, medical records staff, and front desk staff, gives
them the potential to bridge gaps in information that
might otherwise impede innovation implementation. To
bridge these gaps, middle managers must commit to
innovation implementation. Middle managers’ commit-
ment to healthcare innovation implementation is a beha-
vioral manifestation of middle managers’ effort and
engagement in activities that promote innovation imple-
mentation. Specifically, we posit that middle managers
express their commitment to healthcare innovation
implementation by diffusing and synthesizing informa-
tion regarding innovation implementation, mediating
between strategy and the day-to-day activities required to
implement innovations, and selling innovation imple-
mentation. These expressions of middle managers’ com-
mitment to healthcare innovation implementation
include a variety of activities. For example, as we discuss
in detail below, selling innovation implementation might
involve setting innovation implementation-related
norms. Middle managers’ influence is likely to be bidirec-
tional: They may disseminate information vertically, from
top managers to frontline employees and from frontline
employees to top managers, and horizontally, across top
managers and across frontline employees.
To effectively implement healthcare innovations,
employees require the following types of information:
compilation (integrating facts); meta-cognition (interpret-
ing facts); declarative (what to do); procedural (how to do
things); and conditional or tacit (when and why to do
things) [46,47]. Because middle managers fill structural
holes in healthcare organizations, they may bridge the
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tively implement healthcare innovations by doing the fol-
lowing:
1. Diffusing information. Middle managers dissemi-
nate facts, giving employees necessary information
about innovation implementation. For example, mid-
dle managers who oversaw HDC implementation
informed employees that the HDC involved schedul-
ing chronic care follow-up appointments anticipato-
rily [44].
2. Synthesizing information. Middle managers inte-
grate and interpret facts, making general information
about innovation implementation relevant to unique
organizations and employees. For some middle man-
agers who oversaw HDC implementation, this involved
introducing new systems of patient flow in which front
desk staff scheduled chronic care follow-up appoint-
ments directly following a visit (anticipatorily) instead
of waiting for patients to call for an appointment [44].
3. Mediating between strategy and day-to-day activ-
ities. Middle managers identify tasks required for
implementing innovations, giving employees the tools
necessary to implement innovations. For example,
middle managers who oversaw HDC implementation
explained how to use appointment systems to schedule
chronic care follow-up appointments anticipatorily
[44].
4. Selling innovation implementation. Middle man-
agers justify innovation implementation, encouraging
employees to consistently and effectively use innova-
tions. For example, HDC middle managers explained
that using appointment systems to schedule chronic
care follow-up appointments would minimize the need
for episodic acute care, improve patient outcomes, and
afford greater control over appointment schedules
[44].
In turn, we posit, middle managers’ commitment to
healthcare innovation implementation contributes to an
organization’s implementation climate–employees’
shared perceptions of the extent to which innovation
implementation is rewarded, supported, and expected
[48]. Middle managers who oversaw HDC implementa-
tion, for example, used online tools to find ideas to meet
their health centers’ needs (an expression of commitment
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Figure 1 Middle managers’ role in healthcare innovation implementation.
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that compelled employees to implement the HDC [44]. A
strong implementation climate promotes implementation
effectiveness–consistent, high-quality innovation use
[16]. Health centers in which middle managers contribu-
ted to an environment in which employees felt compelled
to implement the HDC exhibited more consistent, higher
quality HDC use [44]. For example, some middle man-
agers overseeing HDC implementation sought technical
assistance from the Health Resources and Services
Administration’s Bureau of Primary Health Care and
relayed the assistance to employees. In so doing, middle
managers contributed to an environment in which
employees felt compelled to implement the HDC.
Middle managers’ ability and willingness to express their
commitment to innovation implementation is influenced
by implementation policies and practices or IP&Ps–’the
plans, practices, structures and strategies that an organiza-
tion employs...to support innovation [implementation]’
[49]. For example, middle managers who underwent per-
formance reviews about HDC-related performance (an
IP&P) were more inclined than middle managers who did
not undergo such performance reviews to regularly use
online tools (an expression of commitment to HDC imple-
mentation) [44]. We describe relationships among IP&Ps,
middle managers’ commitment, implementation climate,
and implementation effectiveness below in turn.
Middle managers diffuse information regarding
innovation implementation
Middle managers disseminate facts about innovation
implementation, giving employees necessary information
about innovation implementation. Middle managers’
proximity to both top managers’ strategic decisions and
frontline employees’ day-to-day operations may allow
them to relay information regarding innovation implemen-
tation to employees. Specifically, staying attuned to top
managers’ and frontline employees’ moods and needs may
allow middle managers to provide frontline employees
with the information necessary to implement innovations
and top managers with feedback regarding innovation
implementation status and needs [50,51]. Middle man-
agers overseeing the implementation of the HDC, for
example, were tasked with explaining to providers that the
HDC would require developing a patient registry. When
providers resisted completing the flow sheets used to
gather data for the patient registry, middle managers
informed top managers of providers’ resistance [44].
Scholars in industries other than healthcare have found
that middle managers diffuse information regarding
innovation implementation. One study found that middle
managers in a utility company diffused information
regarding an innovation by fielding employees’ questions
[52]. Another study of organizations outside healthcare
found that middle managers used logical presentations of
information to attempt to influence top managers [53].
Diffusing information regarding innovation implementa-
tion may be particularly important in healthcare organiza-
tions. Regulatory pressures and industry standards often
make it difficult for employees in healthcare organizations
to prioritize tasks. For example, nurses often simulta-
neously contend with meeting regulatory and professional
standards and attending to their organizations’ QI initia-
tives. By disseminating information, middle managers
draw employees’ attention to innovation implementation.
As information brokers, middle managers contribute to
a climate in which innovation implementation is perceived
as rewarded, supported, and expected in an organization.
By disseminating facts about innovation implementation,
middle managers inform employees of an innovation that
is expected to be implemented. Ideally, middle managers
also disseminate information regarding material or emo-
tional support for innovation implementation and rewards
for innovation implementation such as financial incentives
or public recognition. As we describe in detail below, mid-
dle managers’ ability and willingness to diffuse information
is influenced by IP&Ps.
Middle managers synthesize information regarding
innovation implementation
Middle managers integrate and interpret facts, making
general information about innovation implementation
relevant to unique organizations and employees [51,54].
For example, middle managers who oversaw the imple-
mentation of the HDC distilled the knowledge that they
acquired at national HDC conferences into information
that was relevant to their health centers [44]. Synthesizing
information may involve activities such as monitoring
employees’ responses to the information; if middle man-
agers find that an employee has misunderstood the infor-
mation, they may reinterpret the information in a way that
the employee may find more relevant.
Researchers in industries other than healthcare have
found that middle managers process information regard-
ing innovation implementation so that it may be useful to
employees. Dopson and Stewart, for example, found that
middle managers in manufacturing and public sector orga-
nizations had a unique vantage that made them privy to
issues both within and outside the organization [55]. As a
result, middle managers were able to obtain pertinent out-
side information, which frontline employees could use to
gain competitive and strategic advantage for their organi-
zation. Similarly, middle managers in textile companies
who were privy to information regarding key mechanisms
for their organization’s competitive advantage were able to
contribute to implementation effectiveness by conveying
the information to appropriate employees throughout
the organization [36]. Mantere also found that middle
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employees understand key information regarding innova-
tion implementation [56].
Synthesizing information for employees tasked with
innovation implementation mayb ep a r t i c u l a r l yc h a l l e n -
ging in healthcare organizations. Hospital teams, for
example, are often comprised of hospital employees, such
as technicians and nurses, as well as non-staff physicians.
Making innovation-related information relevant to this
diverse array of employees may be challenging. Because
middle managers often span organizational boundaries
[57], they may be particularly helpful in bridging infor-
mational gaps.
Synthesizing information regarding innovation imple-
mentation may contribute to a climate in which innova-
tion implementation is perceived as rewarded, supported,
and expected in an organization. For example, middle
managers who oversaw the implementation of the HDC
synthesized the information that they obtained from
online tools for use in their own unique health centers
[44]. Interpreting facts about innovation implementation
may convey to employees the relevance of the innovation
to the specific roles that they are expected to fulfill. Inter-
preting facts about innovation implementation may also
involve explaining to employees the specific ways in which
someone in their role would be supported and rewarded
for innovation implementation. Again, as we describe in
detail below, middle managers’ ability and willingness to
synthesize information is influenced by IP&Ps.
Middle managers mediate between strategy and day-to-
day activities
Middle managers identify tasks required for implement-
ing innovations, giving employees the tools necessary to
implement innovations [58]. In addition to diffusing and
synthesizing information, middle managers translate
information into concrete tasks that must be carried out
to effectively implement innovations. Indeed, Uyterhoe-
ven suggested that middle managers assume the ‘bilin-
gual’ role of translating strategy into actionable tasks
[58]. For example, HDC implementation required health
centers to maintain a patient disease registry. To facilitate
data collection, middle managers who oversaw HDC
implementation introduced new patient flow sheets,
developed systems to route patient health records, gener-
ated data reports, and troubleshot registry software [44].
S e v e r a ls c h o l a r so u t s i d et h eh e a l t h c a r ei n d u s t r yh a v e
found that middle managers’ generalist skills allow them
the flexibility and adaptability required to translate broad
strategy into concrete tasks for implementation [55]. For
example, Kanter found that middle managers carried out
strategy by giving employees the tools for innovation
implementation and practical feedback on their innova-
tion implementation-related performance [59]. Kodama
found that middle managers in technology firms trans-
cended divisional barriers to form ‘strategic communities’
that promoted the implementation of new technologies
[60].
Middle managers’ ability to translate strategy into
actionable tasks may be particularly important in health-
care organizations. Top managers in healthcare organiza-
tions, particularly chief executive officers, are often not
clinicians [61]. Middle managers in healthcare organiza-
tions, on the other hand, are often clinicians such as
nurses who have taken on managerial roles. As such,
middle managers can translate top managers’ strategy,
which may seem far removed from clinicians’ priorities,
into actionable tasks for the clinicians who implement
innovations in healthcare organizations.
By mediating between strategy and day-to-day activities,
middle managers contribute to a climate in which innova-
tion implementation is perceived as rewarded, supported,
and expected in an organization: Middle managers may
identify specific activities in which employees are expected
to engage to promote an organization’s strategy of innova-
tion implementation. In mediating between strategy and
day-to-day activities, middle managers also imply that
employees will be supported in promoting an organiza-
tion’s strategy of implementing innovations; if employees
know what they must do to promote their organization’s
strategy, they may feel more equipped to do so [47].
Mediating between strategy and day-to-day activities iden-
tifies specific activities in which employees may engage to
earn associated rewards such as financial incentives. For
example, introducing new patient flow sheets conveyed to
providers implementing the HDC that data collection was
an expected component of patient care. It also suggested
that their health centers could support them with the
tools necessary to develop and maintain patient registries.
And some middle managers who oversaw HDC imple-
mentation discussed with providers that using the new
patient flow sheets promoted accurate data related to their
performance in managing chronic diseases; in turn, accu-
rate performance data would yield fair rewards [44].
Again, as we describe in detail below, middle managers’
ability and willingness to mediate between strategy and
day-to-day activities is influenced by IP&Ps.
Middle managers sell innovation implementation
Middle managers justify innovation implementation,
encouraging employees to consistently and effectively use
innovations [54]. Translating operational information into
concrete tasks may be necessary but insufficient to pro-
mote effective implementation: Employees must consider
execution of those tasks to be a worthy use of their time.
By convincing employees that innovation implementation
is worthy of their attention, middle managers obtain
employees’ support for innovation implementation. To
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who oversaw HDC implementation encouraged them to
view the HDC as an efficient way of staying abreast of
state-of-the-art clinical practices [44]. Selling innovation
implementation may involve setting innovation implemen-
tation-related norms. For example, some middle managers
who oversaw HDC implementation worked to incorporate
data collection into routine health center operations by
collecting data themselves and creating systems to encou-
rage others to collect data. Selling innovation implementa-
tion may also involve leadership. For example, some
middle managers who oversaw HDC implementation
viewed maintaining a positive attitude regarding innova-
tion implementation for the benefit of the employees
whom they supervised as central to their role in innova-
tion implementation.
Several researchers in industries other than healthcare
have found that middle managers champion innovation
implementation, encouraging employees to implement
innovations. Rouleau (2005) found that middle managers
in a Canadian clothing manufacturing organization
helped employees to appreciate the rationale underlying
organizational changes, thereby promoting innovation
implementation [62]. Similarly, Ogbonna and Wilkinson
found that middle managers in a food retail company
considered central to their role encouraging employees
to implement an innovation [43]. Another study found
that middle managers in a European professional service
influenced both the opinions and activities of frontline
employees and their supervisors through daily conversa-
tions, subsequently increasing implementation effective-
ness [56].
Selling innovation implementation may be particularly
important in healthcare organizations. As noted above,
clinical and administrative staff often contends with
meeting regulatory and professional standards and
attending to their organization’s service and QI initia-
tives. By conveying the importance of implementing a
particular innovation, middle managers encourage
employees to prioritize innovation implementation.
By selling innovation implementation, middle managers
contribute to a climate in which innovation implementa-
tion is perceived as rewarded, supported, and expected in
an organization. Selling innovation implementation sug-
gests that middle managers consider innovation imple-
mentation to be worthy of their own attention and,
therefore, other employees’ attention; that is, innovation
implementation is expected of employees. Many middle
managers overseeing HDC implementation, for example,
viewed themselves as role models; they believed that enga-
ging in HDC-related activities encouraged employees to
do so as well [44]. Suggesting that innovation implementa-
tion is worthy of middle managers’ attention implies that
employees will be supported in implementing innovations:
If middle managers have the resources necessary to imple-
ment innovations, ostensibly, so will other employees.
Middle managers are likely to know how employees can
successfully fulfill their roles. When middle managers sell
innovation implementation, employees may believe that
engaging in activities to promote innovation implementa-
tion will confer the rewards associated with successfully
fulfilling their implementation-related roles. For example,
some middle managers reported that being publicly recog-
nized for their HDC-related efforts encouraged employees
to engage in HDC-related activities. And when employees
saw that some middle managers were discouraged by lack
of support from top managers for HDC implementation,
their efforts flagged [44]. Again, as we describe in detail
below middle managers’ ability and willingness to sell
innovation implementation is influenced by IP&Ps.
The influence of implementation policies and practices on
middle managers’ role in healthcare innovation
implementation
We posit that whether or not middle managers influence
healthcare innovation implementation and whether their
influence is positive or negative is influenced by IP&Ps–
’the plans, practices, structures and strategies that an orga-
nization employs...to support innovation [implementation]’
[49]. The theory of perceived organizational support, a
social exchange interpretation of commitment, provides a
framework for understanding how IP&Ps may increase
middle managers’ ability and willingness to express their
commitment to innovation implementation [63]. The the-
ory’s premise is that employees such as middle managers
anthropomorphize their organizations, attributing the
actions of organizational agents (e.g., top managers) to the
organization’s intent [64]. Organizational agents’ actions
are often responses to the organization’s legal, financial,
and moral responsibilities, and its policies, practices, and
culture, but middle managers who anthropomorphize
their organizations view organizational agents’ actions as
an indicator of the extent to which their organization
favors an initiative such as innovation implementation. For
example, incentives (an IP&P) were sometimes offered to
middle managers whose teams effectively implemented
the HDC. Middle managers may have viewed the incen-
tives as an indication that their organization valued HDC
implementation [44]. Middle managers may develop affec-
tive attachment to innovation implementation because
they believe that IP&Ps are a sign that their organization
cares about the innovation. As another example, perfor-
mance reviews about HDC-related performance (an IP&P)
signaled to middle managers that the HDC was important
to their health centers [44]. This may cause middle man-
agers to commit to innovation implementation, contribut-
ing to a climate in which innovation implementation is
viewed as rewarded, supported, and expected.
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role in healthcare innovation implementation
Whether middle managers influence healthcare innovation
implementation, the ways in which they influence health-
care innovation implementation, and whether their influ-
ence is positive or negative warrants empirical research.
Such research will fill a gap in extant health services
research and will identify ways of encouraging middle
managers to positively influence innovation implementa-
tion. Middle managers’ role may be particularly important
for healthcare innovation implementation because they
can encourage employees to prioritize innovation imple-
mentation amidst many competing demands; transcend
complex staffing and operations to provide relevant infor-
mation regarding innovation to employees; leverage their
position over project teams to promote innovation imple-
mentation; and translate organizational strategy into clini-
cally relevant terms. Indeed, middle managers have a
poorly understood yet potentially critical role in healthcare
innovation implementation.
Summary
The role of top managers and physicians has garnered
more attention than the role of middle managers in the
small but growing research literature on healthcare inno-
vation implementation–the transition period when
employees become adept at using a new practice. Extant
theory and research point to physician buy-in and top
managers’ commitment as key determinants of implemen-
tation effectiveness–the consistency and quality of targeted
organizational members’ u s eo fa ni n n o v a t i o n[ 1 6 ] .L e s s
theorized or studied is middle managers’ role. Teamwork
designs have become popular in healthcare organizations
[1]. Because middle managers oversee these team initia-
tives, their influence over innovation implementation has
grown [3]. The omission of middle managers from
research on healthcare innovation implementation is parti-
cularly problematic because middle managers in health-
care organizations are unique. Many middle managers are
promoted based on clinical skills but may lack the skills to
run a department or service area [65]. In addition, middle
managers’ role in healthcare innovation implementation
may differ from the role of middle managers in other
industries because middle managers in healthcare organi-
zations often assume their management role in addition to
clinical responsibilities. Understanding middle managers’
role in innovation implementation is critical for improving
implementation effectiveness in healthcare organizations.
Future research should fill the current gap in extant health
services research by investigating middle managers’ role in
healthcare innovation implementation. Ideally, this
research will identify ways of encouraging middle man-
agers to positively influence healthcare innovation
implementation.
Future research on middle managers’ role in healthcare
innovation implementation
Future healthcare innovation implementation research
should address the following questions: Do middle man-
agers influence healthcare innovation implementation, and
under what conditions? Is middle managers’ influence on
healthcare innovation implementation positive or negative,
and under what conditions? What are the factors that
influence middle managers’ commitment to innovation
implementation? In what ways do middle managers influ-
ence healthcare innovation implementation? Pursuing
each of these questions may be facilitated by using the the-
o r yo fm i d d l em a n a g e r s ’ role in healthcare innovation
implementation presented in this paper.
An initial study of middle managers’ role in healthcare
innovation implementation would ideally use empirical
data to assess whether middle managers influence imple-
mentation effectiveness and, if so, whether their influence
is positive or negative. Such a study might address this
question by assessing the relationship between middle
managers’ commitment to innovation implementation–
that is, behavioral manifestations of middle managers’
effort and engagement in activities that promote innova-
tion implementation–and implementation effectiveness.
To ensure that the question is adequately addressed, the
study must include middle managers with varying
degrees of commitment and multiple healthcare organi-
zations implementing a single innovation with varying
degrees of effectiveness. This would ensure a consistent
measure of implementation effectiveness and produce
generalizable results.
Assessing the conditions under which middle managers
influence healthcare innovation implementation and the
conditions under which middle managers’ influence is
positive or negative could begin with studying relation-
ships among IP&Ps, middle managers’ commitment, and
implementation effectiveness. We posit in our theory of
middle managers’ role in healthcare innovation imple-
mentation that middle managers’ ability and willingness
to engage in innovation implementation-related roles is
influenced by IP&Ps. To investigate this theory, health
services researchers could assess whether middle man-
agers’ commitment mediates relationships between
IP&Ps and implementation effectiveness. Alternatively,
IP&Ps may moderate the relationship between middle
managers’ commitment and implementation effective-
ness. Both possibilities should be explored in future
studies.
Many other variables, such as organizational size, com-
plexity, formalization, and centralization may also moder-
ate the relationship between middle managers’
commitment to healthcare innovation implementation
and implementation effectiveness. For example, middle
managers’ commitment may have a weak or nonexistent
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highly centralized healthcare organizations. In these
types of organizations, middle managers may have little
autonomy, or their role may be indistinguishable from
that of top managers. This may be particularly true in
small primary care practices in which a single employee
fulfills the roles of both top and middle manager.
If, indeed, middle managers’ commitment has a rela-
tionship with healthcare innovation implementation
effectiveness, a subsequent study could assess the ways in
which middle managers influence healthcare innovation
implementation. Such a study may address this question
by determining whether the roles proposed in our theory
of middle managers’ role in healthcare innovation imple-
mentation mediate the relationship between middle man-
agers’ commitment and implementation effectiveness and
how these roles influence implementation climate. For
example, middle managers may prioritize diffusing infor-
mation over selling innovation implementation. And
some roles may contribute to an environment in which
innovation implementation is perceived as expected, sup-
ported, and rewarded more than other roles. Perhaps, for
example, employees feel most compelled to implement
innovations when middle managers sell innovation
implementation by role-modeling. This information
could help top managers to support middle managers in
engaging in their roles as effectively as possible. Ideally, a
quantitative study would be paired with qualitative meth-
ods to gain deeper knowledge of the ways in which mid-
dle managers influence healthcare innovation
implementation.
Studies of middle managers’ role in healthcare innova-
tion implementation would likely pose several conceptual
challenges. For example, defining middle managers may
not be straightforward. Borrowing from Noble, we concep-
tualized middle managers as employees who supervise
other employees in the organization and are supervised by
top managers [2]. However, middle managers may fill
positions one, two, three, or more levels below top man-
agers [66]. Middle managers in healthcare organizations
m a yb ee v e nm o r ed i f f i c u l tt od e f i n eb e c a u s et h e yo f t e n
have diverse professional backgrounds. Middle managers
who oversaw the implementation of the HDC, for exam-
ple, were represented by physicians, nurses, social workers,
and administrators [44]. Further, middle managers in
healthcare organizations often have diverse functions;
instead of supervising a consistent set of frontline employ-
ees, healthcare organizations’ teamwork designs require
middle managers to simultaneously oversee several pro-
jects. Middle managers in healthcare organizations also
tend to occupy a variety of positions. Many middle man-
agers who oversaw HDC implementation, for example,
had both administrative and clinical responsibilities [44].
Initial empirical research on middle managers’ role in
healthcare innovation implementation would ideally adopt
a broad definition of middle managers. Subsequent
research, however, should consider various definitions of
middle managers as moderators of the relationship
between middle managers’ commitment to healthcare
innovation implementation and implementation
effectiveness.
For several reasons, studying middle managers’ role in
healthcare innovation implementation may also be metho-
dologically challenging. For example, as mentioned above,
a study of the relationship between middle managers’
commitment to innovation implementation and imple-
mentation effectiveness would assess middle managers’
commitment to a single innovation in multiple healthcare
organizations. Finding a single innovation that is simulta-
neously implemented in multiple healthcare organizations
is likely to be challenging. Such a study might benefit from
capitalizing on multiple healthcare organizations’ imple-
mentation of innovations required by an accrediting body.
In addition, researchers must account for the multi-level
nature of middle managers’ role in innovation implemen-
tation. Specifically, our theory suggests that IP&Ps (organi-
zation-level constructs) influence middle managers’ ability
and willingness to express their commitment to innova-
tion implementation (an individual-level behavior). By dif-
fusing information, synthesizing information, mediating
between strategy and day-to-day activities, and selling
innovation implementation, middle managers contribute
to a climate in which innovation implementation is
rewarded, supported, and expected (an organization-level
construct). This implementation climate promotes consis-
tent, high-quality innovation use (an organization-level
construct; see Figure 1). Researchers must carefully
address these multi-level issues to promote clear under-
standing of middle managers’ role in healthcare innovation
implementation.
Implications for practice
The theory of middle managers’ role in healthcare innova-
tion implementation described in this paper suggests that
top managers in healthcare organizations may neglect a
potentially important determinant of implementation
effectiveness. Leveraging middle managers’ role may have
the potential to increase implementation effectiveness in
healthcare. Specifically, the theory of middle managers’
role in healthcare innovation implementation suggests
that middle managers may influence healthcare innovation
implementation in the following ways: diffusing informa-
tion regarding innovation implementation; synthesizing
information regarding innovation implementation; mediat-
ing between strategy and the day-to-day activities required
to implement innovations; and selling innovation imple-
mentation. Top managers in healthcare organizations may
promote implementation effectiveness by encouraging
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managers could promote the fulfillment of these roles by:
Ensuring that middle managers are privy to strategy
related to innovation implementation; without information
regarding strategy, middle managers would lack the
knowledge required to educate, support, and encourage
employees to implement innovations; giving middle man-
agers the freedom to educate, support, and encourage
employees; ensuring that middle managers have access to
resources necessary to translate strategy into day-to-day
activities; for example, if top managers envision informa-
tion systems to be a key strategy for implementing an
innovation such as the HDC, then middle managers will
require information systems training to better support
employees’ use of the technology; and expressing their
own commitment to innovation implementation; doing so
would convey to employees consistent commitment to
innovation implementation throughout the organization.
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